Viking Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Go back to Viking Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 37.87 +3.06 (8.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.81 | 52 Week High | $5.17 | |||
| Open | $35.63 | 52 Week Low | $0.94 | |||
| Day High | $38.08 | P/E | N/A | |||
| Day Low | $35.03 | EPS | $0.00 | |||
| Volume | 5,563,655 | |||||
